Open original FDA record ↗Recall record
- FDA identifier
- Z-2610-2025
- Company in FDA record
- Medline Industries, LP
- FDA classification date
- Sep 26, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Specific lots of reprocessed electrophysiology and ultrasound catheters may contain small residual particulates. If devices with residual particulates on patient-contacting surfaces are used, there is a potential risk of an inflammatory response or systemic infection, and if particulate were to dislodge during use and contact circulating blood and/or the heart, it may produce a granulomatous reaction or thrombus formation, which may lead to cerebral or pulmonary embolism, or deep vein thrombosis.
Source facts
- Action
- On July 31, 2025, the firm notified customers via first class mail and email of the potential product issue. An updated letter was sent to customers on 8/13/25 with additional item and lot numbers. Affected products are to be returned for credit. Customers were instructed to immediately identify and quarantine all affected product within their possession. Once they have completed and returned the response form listing their affected inventory, they will receive return labels and RGA information. Customers will receive credit when the returned product is received.
- Initiated
- 2025-07-31
- Root cause
- Under Investigation by firm
- Distribution
- Domestic US distribution nationwide. International distribution pending. No international distribution.
- Recall number
- Z-2610-2025
- Recall status
- Open, Classified
- CDRH record ID
- 215765
- FDA classified
- 2025-09-26
- Recall event number
- 97496